First UK trial of AIDS vaccine approved
نویسندگان
چکیده
منابع مشابه
The ethical design of an AIDS vaccine trial in Africa.
In 1987 in Zaire, a French investigator and a small group of Zairians were immunized with a French investigational AIDS vaccine. This action leads to questioning whether different sociocultural settings should have different research ethics applied, especially on pandemic diseases. Another question is to clarify the valid reasons for conducting an AIDS trial in Africa. The design of an AIDS ...
متن کاملFirst Steps toward a Globally Effective HIV/AIDS Vaccine
The enormous diversity of HIV-1 presents a formidable challenge for developing an effective AIDS vaccine. In this issue of Cell, Barouch et al. show that bioinformatically designed antigens, pieced together from multiple HIV immune epitopes, partially protect rhesus macaques from simian-human immunodeficiency virus infection. This "mosaic" approach holds promise for the development of broadly p...
متن کاملCCR Drug Updates PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Sipuleucel-T (PROVENGE; Dendreon) is the first therapeutic cancer vaccine to be approved by the U.S. Food and Drug Administration. In men who have metastatic castration-resistant prostate cancer with no or minimal symptoms, sipuleucel-T prolongs median survival by 4.1 months compared with results in those treated with placebo. At 3 years, the proportion of patients in the vaccine group who were...
متن کاملPROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.
Sipuleucel-T (PROVENGE; Dendreon) is the first therapeutic cancer vaccine to be approved by the U.S. Food and Drug Administration. In men who have metastatic castration-resistant prostate cancer with no or minimal symptoms, sipuleucel-T prolongs median survival by 4.1 months compared with results in those treated with placebo. At 3 years, the proportion of patients in the vaccine group who were...
متن کاملFirst DNA malaria vaccine on trial in Africa
Scientists from Oxford have taken another step along the frustrating route to an effective malaria vaccine. This autumn, Vasee Moorthy of Oxford University’s Department of Clinical Medicine, working with scientists at the Medical Research Council’s Laboratories in the Gambia, began trials of new DNA-based vaccines against the malaria parasite Plasmodium falciparum. The vaccines, developed by Ad...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1990
ISSN: 0028-0836,1476-4687
DOI: 10.1038/346303a0